GTP Regimen in the Treatment of Refractory/Recurrent HLH

Clinical trial NCT06038422 · UNKNOWN

Trial details

NCT number: NCT06038422
Sponsor: Beijing Friendship Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Refractory Recurrence Hemophagocytic Lymphohistiocytosis

Start date: 2023-09-15
Primary completion: 2024-09-15
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.